Mountain Pacific Investment Advisers Inc. ID Has $19.69 Million Position in Teleflex Incorporated (NYSE:TFX)

Mountain Pacific Investment Advisers Inc. ID boosted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 1.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 78,958 shares of the medical technology company’s stock after purchasing an additional 835 shares during the quarter. Mountain Pacific Investment Advisers Inc. ID owned about 0.17% of Teleflex worth $19,687,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. Allworth Financial LP lifted its stake in shares of Teleflex by 332.3% during the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock worth $26,000 after buying an additional 103 shares during the last quarter. Venturi Wealth Management LLC acquired a new stake in Teleflex during the 3rd quarter worth approximately $27,000. Covestor Ltd boosted its stake in Teleflex by 305.6% in the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 110 shares during the period. Lindbrook Capital LLC grew its holdings in Teleflex by 75.3% in the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after buying an additional 58 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its holdings in Teleflex by 418.5% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock valued at $35,000 after buying an additional 113 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

TFX stock opened at $206.71 on Friday. The company has a market capitalization of $9.74 billion, a P/E ratio of 27.45, a PEG ratio of 2.02 and a beta of 1.11. The company has a fifty day moving average price of $221.23 and a 200-day moving average price of $225.61. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $276.43.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The business had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. During the same quarter in the prior year, the firm posted $3.52 EPS. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. As a group, equities analysts expect that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were given a dividend of $0.34 per share. The ex-dividend date was Thursday, February 29th. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. Teleflex’s payout ratio is 18.06%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on TFX shares. Royal Bank of Canada lowered their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. JMP Securities reaffirmed a “market outperform” rating and issued a $285.00 price objective on shares of Teleflex in a report on Friday, February 23rd. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Finally, Truist Financial dropped their price target on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and a consensus price target of $267.50.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the completion of the sale, the vice president now owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.43% of the stock is currently owned by corporate insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.